Cargando…
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice
Current genetically-engineered mouse melanoma models are often based on Tyr::CreER(T2)-controlled MAPK pathway activation by the BRAF(V600E) mutation and PI3K pathway activation by loss of PTEN. The major drawback of these models is the occurrence of spontaneous tumors caused by leakiness of the Tyr...
Autores principales: | Deken, Marcel A., Song, Ji-Ying, Gadiot, Jules, Bins, Adriaan D., Kroon, Paula, Verbrugge, Inge, Blank, Christian U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187949/ https://www.ncbi.nlm.nih.gov/pubmed/27999416 http://dx.doi.org/10.3390/ijms17122149 |
Ejemplares similares
-
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015) -
Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
por: Esobi, Ikechukwu, et al.
Publicado: (2022) -
Mast cell-specific Cre/loxP-mediated recombination in vivo
por: Scholten, Julia, et al.
Publicado: (2007) -
Viral Cre-LoxP tools aid genome engineering in mammalian cells
por: Sengupta, Ranjita, et al.
Publicado: (2017) -
Construction of Marker-Free Transgenic Strains of Chlamydomonas reinhardtii Using a Cre/loxP-Mediated Recombinase System
por: Kasai, Yuki, et al.
Publicado: (2016)